In contrast, cerebral ischemia greatly elevated the concentration of ECF-Zn, which then binds to ECF-MMP-2 and activates the enzyme, leading to ischemia-induced occludin degradation and BBB disruption. The gene discussed is OCLN; the disease is Cerebral ischemia.